Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.SummaryDifference0.5%

- Check12 days agoChange DetectedAdded a funding/operational status notice at the top of the page and updated the revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' field to improve readability and data transparency. The previous 'Last Update Submitted that met QC Criteria' label and the 'No FEAR Act data' text were adjusted, and the page includes a new revision tag 'v3.4.0'.SummaryDifference0.3%

- Check34 days agoChange DetectedSite revision label updated to Revision: v3.3.4; the previous Revision: v3.3.3 label was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 references have been removed.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.